These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10685444)
21. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae. Barchiesi F; Arzeni D; Compagnucci P; Di Francesco LF; Giacometti A; Scalise G Med Mycol; 1998 Dec; 36(6):437-40. PubMed ID: 10206757 [TBL] [Abstract][Full Text] [Related]
23. Etest for assessing the susceptibility of filamentous fungi. Dóczi I; Dósa E; Varga J; Antal Z; Kredics L; Nagy E Acta Microbiol Immunol Hung; 2004; 51(3):271-81. PubMed ID: 15571067 [TBL] [Abstract][Full Text] [Related]
25. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
26. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula. Serena C; Mariné M; Pastor FJ; Nolard N; Guarro J J Antimicrob Chemother; 2005 Jun; 55(6):1020-3. PubMed ID: 15845779 [TBL] [Abstract][Full Text] [Related]
27. In vitro susceptibility pattern of Sporothrix schenckii strains isolated from three centers in India. Ghosh A; Chakrabarti A; Hemashettar BM; Maiti PK Indian J Med Res; 2001 Jun; 113():214-20. PubMed ID: 11816955 [TBL] [Abstract][Full Text] [Related]
28. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds]. Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249 [TBL] [Abstract][Full Text] [Related]
29. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Pfaller MA; Castanheira M; Messer SA; Jones RN Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853 [TBL] [Abstract][Full Text] [Related]
30. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration]. Alvarado D; Díaz MC; Silva V Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility of clinical isolates of yeasts to anti-fungal agents. Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980 [TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital. Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705 [TBL] [Abstract][Full Text] [Related]
33. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
34. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole. Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects. Vitale RG; De Hoog GS; Verweij PE Med Mycol; 2003 Aug; 41(4):301-7. PubMed ID: 12964723 [TBL] [Abstract][Full Text] [Related]
36. In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates. Skóra M; Macura AB; Bulanda M Med Mycol; 2014 Oct; 52(7):723-7. PubMed ID: 25049036 [TBL] [Abstract][Full Text] [Related]
37. Meningitis caused by Rhodotorula rubra in an HIV-infected patient. Gyaurgieva OH; Bogomolova TS; Gorshkova GI J Med Vet Mycol; 1996; 34(5):357-9. PubMed ID: 8912171 [TBL] [Abstract][Full Text] [Related]
38. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
39. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole]. Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960 [TBL] [Abstract][Full Text] [Related]
40. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains]. Solgun G; Fındık D; Türk Dağı H; Arslan U Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]